Cargando…

Agomelatine: relief ensured at each and every stage of depression

Detalles Bibliográficos
Autor principal:	Möller, Hans-Jurgen
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991961/ http://dx.doi.org/10.1186/1744-859X-9-S1-S49

Ejemplares similares

Agomelatine: The evidence for its place in the treatment of depression
por: Eser, Daniela, et al.
Publicado: (2010)

Agomelatine for postpartum depression and breastfeeding
por: Xiao, Le
Publicado: (2021)

Efficacy and tolerability of agomelatine in the treatment of depression
por: Plesničar, Blanka Kores
Publicado: (2014)

Pain relief in major trauma patients: an Israeli perspective
por: Zohar, Z, et al.
Publicado: (2002)

Right Care for the Right Patient Each and Every Time
por: Basavatia, Amar, et al.
Publicado: (2016)

Surveillance in surgery prevents infections and ensures good quality of care
por: Vilar-Compte, Diana, et al.
Publicado: (2007)

Agomelatine and its therapeutic potential in the depressed patient
por: Kennedy, Sidney H, et al.
Publicado: (2007)

The need for efficient long-term neuroleptic treatment in schizophrenic patients and the place of long acting injectable antipsychotics
por: Möller, Hans-Jurgen
Publicado: (2010)

The EPA/EADS/ESC position statement on diabetes and cardiovascular risk in patients with severe mental disorders
por: Möller, Hans-Jurgen
Publicado: (2010)

WFSBP Treatment Guidelines and the problem of evidence grading
por: Möller, Hans Jürgen
Publicado: (2010)

Salient beliefs towards the application of an algorithm for pain relief in ICU
por: Beaulieu, D
Publicado: (2002)

Insole-pressure distribution in three pressure-relief postoperative shoes
por: Caravaggi, Paolo, et al.
Publicado: (2014)

Determination of the best volume of perfluorocarbone to ensure partial liquid ventilation in the pig with ARDS
por: Constantin, JM, et al.
Publicado: (1999)

Optimizing pediatric venipuncture: ensuring successful blood sample collection with minimal stress and pain
por: Mauro, Mary Ann, et al.
Publicado: (2014)

Diaspirin cross-linked hemoglobin (DCLHb) ensures tissue oxygenation during hemodilution below the critical hematocrit
por: Kemming, G, et al.
Publicado: (2000)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak, Jan, et al.
Publicado: (2013)

Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks
por: Gahr, Maximilian
Publicado: (2014)

The COX-2-specific inhibitor parecoxib sodium is opioid-sparing and improves pain relief as part of a multimodal treatment strategy
por: Camu, F, et al.
Publicado: (2003)

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]
Publicado: (2013)

Agomelatine Softens Depressive-Like Behavior through the Regulation of Autophagy and Apoptosis
por: Chen, Fengpei, et al.
Publicado: (2021)

Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms
por: Martinotti, Giovanni, et al.
Publicado: (2016)

2237. Outcomes of Metronidazole Dosed Every 12 Hours Versus Every 8 Hours
por: Box, Maggie, et al.
Publicado: (2023)

Emergency dispatch, FirstAED global positioning of first responders with distinct roles - a solution to reduce the response times and ensuring early defibrillation in the rural area Langeland
por: Schakow, Henrik, et al.
Publicado: (2015)

Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study
por: Ivanov, Stanislav V, et al.
Publicado: (2014)

Acute Hepatitis Due to Agomelatine Use in Elderly Women with Depression: Case Series
por: Chang, Cheng-Chen, et al.
Publicado: (2021)

Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder
por: Huang, Juan, et al.
Publicado: (2023)

Efficacy and safety of agomelatine in the treatment of patients with depressive disorder: A meta-analysis
por: Guo, Yue-Han, et al.
Publicado: (2023)

Unpacking collaborative depression care: examining two essential tasks for implementation
por: Bao, Yuhua, et al.
Publicado: (2015)

Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010)

Agomelatine Efficacy in the Night Eating Syndrome
por: Milano, Walter, et al.
Publicado: (2013)

Pain as relief
por: Vázquez, P. García, et al.
Publicado: (2021)

Creation and evaluation of a fidelity measure of collaborative care for maternal depression in Federally Qualified Health Centers
por: Bennett, Ian M, et al.
Publicado: (2015)

Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece
por: Maniadakis, Nikos, et al.
Publicado: (2013)

Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease
por: Chen, Jian-wei, et al.
Publicado: (2018)

Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2023)

Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting
por: Lee, Kyung Ho, et al.
Publicado: (2023)

Metabolic alterations in patients with depression and their relationship to the etiology of depressive disorders
por: Kahl, Kail G
Publicado: (2010)

The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia
por: Wang, Carol Sheei-Meei, et al.
Publicado: (2022)

The pharmacotherapy of depression with EPA
por: Puri, Basant K
Publicado: (2010)

Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression
por: De Berardis, Domenico, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qdqlbii9pbn5hp452vff3lmv49